Figure 1 Disease progression control in PD patients using the Multi-Target Therapy. Historically, the score of PD patients treated only for symptomatic improvement would increase as time went on, affecting their quality of life. In PD patients treated with the Multi-Target Therapy, the disease has less clinical progression in most of the cases during the follow up period.